These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1211398)

  • 1. Recommended system for surveillance and reporting of problems with large-volume parenterals in hospitals.
    Am J Hosp Pharm; 1975 Dec; 32(12):1251-3. PubMed ID: 1211398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Solving problems associated with large-volume parenterals, II: A hospital surveillance and reporting system.
    Zellmer WA
    Am J Hosp Pharm; 1975 Dec; 32(12):1231. PubMed ID: 1211394
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations to pharmacists for solving problems with large-volume parenterals-1979. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):663-7. PubMed ID: 7386474
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the labeling of large volume parenterals. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1978 Jan; 35(1):49-51. PubMed ID: 623118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended procedures for in-use testing of large volume parenterals suspected of contamination or of producing a reaction in a patient. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1978 Jun; 35(6):678-82. PubMed ID: 665681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy.
    Patel JA; Curtis EG; Phillips GL
    Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003
    [No Abstract]   [Full Text] [Related]  

  • 10. 1972 Harvey A. K. Whitney lecture on maturing.
    Heller WM
    Am J Hosp Pharm; 1972 Jul; 29(7):550-5. PubMed ID: 5068467
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures.
    Zellmer WA
    Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overfill of large volume parenterals.
    Turco S; Maza D; Ravin C
    Hosp Pharm; 1978 Jun; 13(6):338, 364. PubMed ID: 10307645
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum in large and small volume parenterals used in total parenteral nutrition--FDA. Proposed rule.
    Fed Regist; 1998 Jan; 63(2):176-85. PubMed ID: 10176836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrogens in small-volume parenterals prepared in hospital pharmacy.
    Lacasa C; Vega FA
    J Parenter Sci Technol; 1989; 43(5):246-9. PubMed ID: 2809933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a database computer program to identify trends in reporting of adverse drug reactions.
    Johnston PE; Morrow JD; Branch RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.